ACQUITY UPLC I-Class/Xevo TQD IVD System: Analytical performance for antiepileptic drugs

The Waters ACQUITY UPLC I-Class/Xevo TQD IVD System enables the quantification of organic compounds in human biological liquid matrices. In this application note, Waters describes a test of the analytical performance of the ACQUITY UPLC I-Class/Xevo TQD IVD system for the analysis of 10,11-dihydro-10-hydroxycarbamazepine, carbamazepine, felbamate, gabapentin, lacosamide, lamotrigine, levetiracetam, oxcarbazepine, perampanel, phenobarbital, phenytoin, pregabalin, primidone, retigabine, tiagabine, topiramate, valproic acid, and zonisamide in plasma. Here, the Waters ACQUITY UPLC I-Class/Xevo TQD IVD System has demonstrated the capability to deliver an analytically sensitive and precise method for the analysis of antiepileptic drugs in plasma.